ReviewMayo Clinic proceedings. Digital health2026
Prediction Models for Periprosthetic Joint Infection: A Systematic Review of Traditional and Machine Learning Approaches.
Review in Mayo Clinic proceedings. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically review the development, validation, and performance of traditional and machine learning (ML) prediction models for periprosthetic joint infection (PJI) risk, diagnosis, and clinical outcomes. Methods: We conducted a systematic review according to PRISMA guidelines to identify studies that developed or validated multivariable prediction models for PJI using traditional statistical or ML approaches. Searches were performed on December 10, 2025, across Ovid Embase, MEDLINE, Scopus, Web of Science, ClinicalTrials.gov, and CENTRAL. Results: Among 4565 identified records, 34 studies met inclusion criteria. Reported discrimination varied across model types and clinical end points. Among traditional risk-prediction models, 54.5% showed acceptable or good discrimination (0.7 ≤ area under the receiver-operating characteristic curve [AUROC] < 0.8), and 27.3% showed excellent discrimination (0.8 ≤ AUROC < 0.9). Traditional diagnostic and outcome prediction models showed good to outstanding discrimination. Among ML models, 50.0% of risk models showed acceptable or good discrimination (0.7 ≤ AUROC < 0.8), while 60.0% of diagnostic models reported AUROC of 0.9 or more. However, calibration reporting was inconsistent, particularly among ML studies, and external validation was limited. Model performance generally decreased in external validation cohorts compared with derivation cohorts. Substantial heterogeneity among included studies and model designs precluded direct crossmodel comparisons; therefore, differences in AUROC should not be interpreted as evidence of superiority between approaches. Conclusion: Prediction models for PJI demonstrate variable performance across risk prediction, diagnosis, and outcome prediction settings. However, substantial clinical and methodological heterogeneity, limited calibration reporting, and inadequate external validation restrict assessment of model reliability and generalizability. Current evidence does not support conclusions regarding the superiority between approaches.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.